1. Home
  2. TTEC vs CNTB Comparison

TTEC vs CNTB Comparison

Compare TTEC & CNTB Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo TTEC Holdings Inc.

TTEC

TTEC Holdings Inc.

HOLD

Current Price

$2.36

Market Cap

128.5M

Sector

Technology

ML Signal

HOLD

Logo Connect Biopharma Holdings Limited

CNTB

Connect Biopharma Holdings Limited

HOLD

Current Price

$2.12

Market Cap

135.7M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
TTEC
CNTB
Founded
1982
2012
Country
United States
United States
Employees
69400
N/A
Industry
Retail: Computer Software & Peripheral Equipment
Biotechnology: Pharmaceutical Preparations
Sector
Technology
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
128.5M
135.7M
IPO Year
1996
2020

Fundamental Metrics

Financial Performance
Metric
TTEC
CNTB
Price
$2.36
$2.12
Analyst Decision
Hold
Strong Buy
Analyst Count
2
3
Target Price
N/A
$8.67
AVG Volume (30 Days)
455.3K
203.0K
Earning Date
05-07-2026
08-13-2026
Dividend Yield
N/A
N/A
EPS Growth
40.80
N/A
EPS
N/A
N/A
Revenue
$1,509,171,000.00
$64,000.00
Revenue This Year
N/A
N/A
Revenue Next Year
$0.10
N/A
P/E Ratio
N/A
N/A
Revenue Growth
2.15
N/A
52 Week Low
$1.98
$0.91
52 Week High
$5.59
$3.82

Technical Indicators

Market Signals
Indicator
TTEC
CNTB
Relative Strength Index (RSI) 44.42 39.96
Support Level $2.12 $2.03
Resistance Level $2.74 $2.68
Average True Range (ATR) 0.17 0.19
MACD -0.02 -0.01
Stochastic Oscillator 38.89 8.33

Price Performance

Historical Comparison
TTEC
CNTB

About TTEC TTEC Holdings Inc.

TTEC Holdings Inc provides customer engagement management tools and services. The company operates through two operating segment, TTEC Digital and TTEC Engage. TTEC Digital is engaged in building and implementing cloud-based and on-premises customer experience tools that enable clients to develop customer engagement strategies. TTEC Engage focuses on delivering sales and marketing solutions to help clients boost their revenue as well as on managing customer's front-to-back office processes to optimize the customer experience. TTEC Engage contributes the vast majority of the company's revenue, and its revenues are derived from the United States and Canada, followed by Philippines, Asia-Pacific and India.

About CNTB Connect Biopharma Holdings Limited

Connect Biopharma Holdings Ltd is a clinical-stage biopharmaceutical company dedicated to transforming care for asthma and chronic obstructive pulmonary disease (COPD). The company is advancing rademikibart, a next-generation antibody designed to target interleukin-4-receptor alpha. It is currently conducting clinical studies of rademikibart for the treatment of acute exacerbations of asthma and COPD. The company operates in one operating segment: treatment of respiratory diseases.

Share on Social Networks: